These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31919642)

  • 41. Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
    Kim JY; Jung EJ; Park HJ; Lee JH; Song EJ; Kwag SJ; Park JH; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC
    Clin Breast Cancer; 2018 Aug; 18(4):e713-e719. PubMed ID: 29217453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PRMT2β, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells.
    Zhong J; Chen YJ; Chen L; Shen YY; Zhang QH; Yang J; Cao RX; Zu XY; Wen GB
    Oncol Rep; 2017 Aug; 38(2):1303-1311. PubMed ID: 28677794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
    Alors-Perez E; Blázquez-Encinas R; Alcalá S; Viyuela-García C; Pedraza-Arevalo S; Herrero-Aguayo V; Jiménez-Vacas JM; Mafficini A; Sánchez-Frías ME; Cano MT; Abollo-Jiménez F; Marín-Sanz JA; Cabezas-Sainz P; Lawlor RT; Luchini C; Sánchez L; Sánchez-Hidalgo JM; Ventura S; Martin-Hijano L; Gahete MD; Scarpa A; Arjona-Sánchez Á; Ibáñez-Costa A; Sainz B; Luque RM; Castaño JP
    J Exp Clin Cancer Res; 2021 Dec; 40(1):382. PubMed ID: 34857016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
    Meng D; Yu Q; Feng L; Luo M; Shao S; Huang S; Wang G; Jing X; Tong Z; Zhao X; Liu R
    Clin Transl Oncol; 2019 Jul; 21(7):910-923. PubMed ID: 30565087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.
    Li P; Xu T; Zhou X; Liao L; Pang G; Luo W; Han L; Zhang J; Luo X; Xie X; Zhu K
    Cancer Med; 2017 Mar; 6(3):662-672. PubMed ID: 28220627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrin α7 high expression correlates with deteriorative tumor features and worse overall survival, and its knockdown inhibits cell proliferation and invasion but increases apoptosis in breast cancer.
    Bai X; Gao C; Zhang L; Yang S
    J Clin Lab Anal; 2019 Oct; 33(8):e22979. PubMed ID: 31325216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
    Wang Z; Liu Q; Chen Q; Zhu R; Zhu HG
    Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):333-8. PubMed ID: 16834906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
    Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
    Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis.
    Zhu L; Yang S; He S; Qiang F; Cai J; Liu R; Gu C; Guo Z; Wang C; Zhang W; Zhang C; Wang Y
    J Mol Histol; 2016 Feb; 47(1):69-80. PubMed ID: 26712154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation.
    Zhao B; Hu X; Zhou Y; Shi Y; Qian R; Wan Y
    Biochem Biophys Res Commun; 2021 Mar; 546():21-28. PubMed ID: 33561744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
    Zhu L; Zhang S; Huan X; Mei Y; Yang H
    Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A PROTAC targets splicing factor 3B1.
    Gama-Brambila RA; Chen J; Zhou J; Tascher G; Münch C; Cheng X
    Cell Chem Biol; 2021 Nov; 28(11):1616-1627.e8. PubMed ID: 34048672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
    Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.
    Jami MS; Hou J; Liu M; Varney ML; Hassan H; Dong J; Geng L; Wang J; Yu F; Huang X; Peng H; Fu K; Li Y; Singh RK; Ding SJ
    BMC Cancer; 2014 Mar; 14():194. PubMed ID: 24628760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-155 promotes the proliferation and migration of breast cancer cells via targeting SOCS1 and MMP16.
    Zhang W; Chen CJ; Guo GL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7323-7332. PubMed ID: 30468477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.